Matches in Nanopublications for { ?s ?p "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP785141.RAD-Dx4UPFZLVUULs2fmWP0NMdCg6aaroK__n6wV5ZZTE130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785141.RAD-Dx4UPFZLVUULs2fmWP0NMdCg6aaroK__n6wV5ZZTE130_provenance.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_provenance.
- NP762177.RAc4l4nmF3dOywrJzyJ00Xh_AiEcK5PHTIrVtgN4jgwF4130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762177.RAc4l4nmF3dOywrJzyJ00Xh_AiEcK5PHTIrVtgN4jgwF4130_provenance.
- NP788104.RAUi0TUmsBCye5gwCTpWsH3Ak0bgSu1doI7tXCmTftN44130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788104.RAUi0TUmsBCye5gwCTpWsH3Ak0bgSu1doI7tXCmTftN44130_provenance.
- assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP754636.RAaRSlm1XhoaBfRUxqWcBqMaF_vPiZzCN78y4ITSeilRE130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754636.RAaRSlm1XhoaBfRUxqWcBqMaF_vPiZzCN78y4ITSeilRE130_provenance.
- assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP569027.RAT6tW_fsPkQFp1XU10t25BPqDTSyhSY6JCITBMU-UakI130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569027.RAT6tW_fsPkQFp1XU10t25BPqDTSyhSY6JCITBMU-UakI130_provenance.
- NP371825.RAjjBNQonQ5E-MyEBukg-IQI0HwImHbAH0J0Z3rIcugXo130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371825.RAjjBNQonQ5E-MyEBukg-IQI0HwImHbAH0J0Z3rIcugXo130_provenance.
- NP569018.RAnGQezeNk1ibELoFnTgGYz-Mlq8bBb_RE57oNiuug0BI130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569018.RAnGQezeNk1ibELoFnTgGYz-Mlq8bBb_RE57oNiuug0BI130_provenance.
- NP569019.RAnIr4ZIhm7uA4ZVn8UoPvl5MkfSzQMuGsHe3j7njWjvA130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569019.RAnIr4ZIhm7uA4ZVn8UoPvl5MkfSzQMuGsHe3j7njWjvA130_provenance.
- NP371842.RA1FolNWSljMjx3YzysX1il4E7Ge52MlGaXguTp3RdVpM130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371842.RA1FolNWSljMjx3YzysX1il4E7Ge52MlGaXguTp3RdVpM130_provenance.
- NP569026.RAExsJl9pLmWpg4ODodGyxLDO2ukqYK5rXlfNqoUtTcr4130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569026.RAExsJl9pLmWpg4ODodGyxLDO2ukqYK5rXlfNqoUtTcr4130_provenance.